Use of Measures of Disproportionality in Pharmacovigilance: Three Dutch Examples

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.6, 2002-01, pp. : 453-458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Date of Drug Marketing on Disproportionality Measures in Pharmacovigilance: The Example of Suicide with SSRIs Using Data From the UK MHRA

By Pariente Antoine Daveluy Amélie Laribière-Bénard Anne Miremont-Salame Ghada Begaud Bernard Moore Nicholas

Drug Safety, Vol. 32, Iss. 5, 2009-01 ,pp. : 441-447

Adis International

Access to resources Recommend Favorite

Measures to strengthen pharmacovigilance in Europe

Reactions Weekly, Vol. 1, Iss. 1242, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Impact of Safety Alerts on Measures of Disproportionality in Spontaneous Reporting Databases: The Notoriety Bias

By Pariente Antoine Gregoire Fleur Fourrier-Reglat Annie Haramburu Françoise Moore Nicholas

Drug Safety, Vol. 30, Iss. 10, 2007-01 ,pp. : 891-898

Adis International

Access to resources Recommend Favorite

Perspectives on the Use of Data Mining in Pharmacovigilance

By Almenoff June

Drug Safety, Vol. 28, Iss. 11, 2005-01 ,pp. : 981-1007

Adis International

Access to resources Recommend Favorite

The Use of Disease-Specific Outcome Measures in Cost-Utility Analysis: The Development of Dutch Societal Preference Weights for the FACT-L Scale

By Lamers Leida M. Groot Carin A. Uyl-de Buijt Ivonne

PharmacoEconomics, Vol. 25, Iss. 7, 2007-01 ,pp. : 591-603

Adis International

Access to resources Recommend Favorite